Cargando…
Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver
Gene expression can be regulated by small non-coding RNA molecules like microRNAs (miRNAs) which act as cellular mediators necessary for growth, differentiation, proliferation, apoptosis, and metabolism. miRNA deregulation is often observed in many human malignancies, acting both as tumor-promoting...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821656/ https://www.ncbi.nlm.nih.gov/pubmed/35145899 http://dx.doi.org/10.3389/fonc.2021.720622 |
_version_ | 1784646447095873536 |
---|---|
author | Pandit, Anuradha Begum, Yasmin Saha, Priyanka Srivastava, Amit Kumar Swarnakar, Snehasikta |
author_facet | Pandit, Anuradha Begum, Yasmin Saha, Priyanka Srivastava, Amit Kumar Swarnakar, Snehasikta |
author_sort | Pandit, Anuradha |
collection | PubMed |
description | Gene expression can be regulated by small non-coding RNA molecules like microRNAs (miRNAs) which act as cellular mediators necessary for growth, differentiation, proliferation, apoptosis, and metabolism. miRNA deregulation is often observed in many human malignancies, acting both as tumor-promoting and suppressing, and their abnormal expression is linked to unrestrained cellular proliferation, metastasis, and perturbation in DNA damage as well as cell cycle. Matrix Metalloproteases (MMPs) have crucial roles in both growth, and tissue remodeling in normal conditions, as well as in promoting cancer development and metastasis. Herein, we outline an integrated interactive study involving various MMPs and miRNAs and also feature a way in which these communications impact malignant growth, movement, and metastasis. The present review emphasizes on important miRNAs that might impact gynecological cancer progression directly or indirectly via regulating MMPs. Additionally, we address the likely use of miRNA-mediated MMP regulation and their downstream signaling pathways towards the development of a potential treatment of gynecological cancers. |
format | Online Article Text |
id | pubmed-8821656 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88216562022-02-09 Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver Pandit, Anuradha Begum, Yasmin Saha, Priyanka Srivastava, Amit Kumar Swarnakar, Snehasikta Front Oncol Oncology Gene expression can be regulated by small non-coding RNA molecules like microRNAs (miRNAs) which act as cellular mediators necessary for growth, differentiation, proliferation, apoptosis, and metabolism. miRNA deregulation is often observed in many human malignancies, acting both as tumor-promoting and suppressing, and their abnormal expression is linked to unrestrained cellular proliferation, metastasis, and perturbation in DNA damage as well as cell cycle. Matrix Metalloproteases (MMPs) have crucial roles in both growth, and tissue remodeling in normal conditions, as well as in promoting cancer development and metastasis. Herein, we outline an integrated interactive study involving various MMPs and miRNAs and also feature a way in which these communications impact malignant growth, movement, and metastasis. The present review emphasizes on important miRNAs that might impact gynecological cancer progression directly or indirectly via regulating MMPs. Additionally, we address the likely use of miRNA-mediated MMP regulation and their downstream signaling pathways towards the development of a potential treatment of gynecological cancers. Frontiers Media S.A. 2022-01-25 /pmc/articles/PMC8821656/ /pubmed/35145899 http://dx.doi.org/10.3389/fonc.2021.720622 Text en Copyright © 2022 Pandit, Begum, Saha, Srivastava and Swarnakar https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Pandit, Anuradha Begum, Yasmin Saha, Priyanka Srivastava, Amit Kumar Swarnakar, Snehasikta Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver |
title | Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver |
title_full | Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver |
title_fullStr | Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver |
title_full_unstemmed | Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver |
title_short | Approaches Toward Targeting Matrix Metalloproteases for Prognosis and Therapies in Gynecological Cancer: MicroRNAs as a Molecular Driver |
title_sort | approaches toward targeting matrix metalloproteases for prognosis and therapies in gynecological cancer: micrornas as a molecular driver |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821656/ https://www.ncbi.nlm.nih.gov/pubmed/35145899 http://dx.doi.org/10.3389/fonc.2021.720622 |
work_keys_str_mv | AT panditanuradha approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver AT begumyasmin approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver AT sahapriyanka approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver AT srivastavaamitkumar approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver AT swarnakarsnehasikta approachestowardtargetingmatrixmetalloproteasesforprognosisandtherapiesingynecologicalcancermicrornasasamoleculardriver |